Where does RhoGAM come from?: The Donor-Driven Process Explained
•
4 min read
Prior to the development of anti-D immune globulin in the 1960s, hemolytic disease of the fetus and newborn (HDFN) was a significant risk in Rh-incompatible pregnancies. This groundbreaking medication, widely known as RhoGAM, comes from a highly specialized process utilizing donated human plasma containing crucial anti-D antibodies.
